Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2023-11-20 00:00:00 ET · period of report 2023-11-20 · accession 0001415889-23-015314 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-20 | 2023-11-20 | FENC | RALLIS CHRIS A | Dir | S - Sale | $8.25 | -269 | 43.0K | -0.6% | -$2,219 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-11-20 | S | D | 269 | $8.25 | 43,034 | D | — | — | (F1) Shares sold pursuant to a 10b5-1 agreement dated March 18, 2022. Sharee sold at a price of $8.25. |